CMP-CPS-001

N/A

Report date: 2026/04/23 20:00:25
NMEFirst In Class

Base Information

Drug NameCMP-CPS-001
Drug Alias NameCMP-CPS-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionCarbamoyl phosphate synthetase 1 stimulants
TargetsCarbamoyl phosphate synthetase 1
Therapy Area/IndicationsUrea Cycle Disorders, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCamp4 Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCamp4 Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsUrea Cycle Disorders, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A